Earningsreport

Q2/2018 6/30/2018 EPS -0.150 ZacksConsensus -0.160 ActVsEst 0.010 - Beat

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com